Popular Articles

Boehringer Ingelheim And DxS Sign An Agreement For A Companion Diagnostic To Identify EGFR Mutations In Patients With Lung Cancer
DxS, a personalised medicine company, and Boehringer Ingelheim, a global group of pharmaceutical companies, headquartered in Germany, have entered into an agreement to provide a companion diagnostic test kit for Boehringer Ingelheim"s compound BIBW 2992 (Tovok™) to identify mutations of the EGFR (epidermal growth factor receptor) in patients with non small cell lung cancer. Financial terms of the agreement are not disclosed.
generic viagra online
Immunotherapy Against Tau Tangles In Alzheimer's Mouse Models
New insights into how a Phase III Alzheimer"s drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - at ICAD.
News of the day
Ongoing Study Shows That Endovascular Therapy Is Associated With High Cure Rate For Childhood Eye Cancer
Expanded results of a study conducted on children with eye cancer (retinoblastoma) shows that chemotherapy delivered through endovascular (through the vessel) means not only successfully cures the cancer in a majority of cases, but achieves this cure with preserved vision. Study outcomes were presented this week at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL by lead author Pierre Gobin, Professor of Radiology in Neurosurgery and Neurology at the Weill Cornell Medical Center at New York Presbyterian Hospital in New York City.
Public Health

Eversheds Comment: NHS Told To Tighten Data Security

Following calls from the information commissioner for the NHS to improve its data security, after breaches involving the loss of thousands of personal medical records, Bill Gilliam, head of the health sector group at international law firm Eversheds comments: "As part of the NHS"s internal procedures, it is important to include clear provisions in employment contracts, setting out obligations relating to confidentiality and security. NHS entities need to consider establishing an internal information security policy that clearly defines their employees" obligations regarding information security, and sets out the consequences of a breach of the policy (eg disciplinary action or dismissal). Confidentiality requirements are of course imposed on NHS professionals by their own regulatory bodies, including the General Medical Council and the Nursing and Midwifery Council. Consequently, breaches of data security by such professionals can adversely affect their registration. It is vital that, as well as having these requirements in place, all personnel are fully alive to the risks of breaching data security and take practical steps to minimise the risks, particularly where data is taken off site. Ironically, it is often the most conscientious individuals, who are taking work home or working whilst in transit, who represent the greatest risk. "In addition, the NHS must ensure that contracts with third party suppliers and other third parties, such as temporary staff and employment agencies, contain clauses referring to confidentiality and security. Having a policy in place that deals with such breaches, and implementing that policy swiftly in the event of any breach, should not only help to mitigate the consequences for the NHS and any individual(s) affected by the security breach, but may mean a more favourable view of the breach is taken by the Information Commissioner (or any other relevant authority) in the event of an investigation. The Information Commissioner (IC) has recently issued further guidance on dealing with data security breaches." Eversheds LLP


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):